Plain-English translation of NCT03571763 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study is following stroke patients who have tiny, usually symptom-free brain bleeds called microbleeds. Researchers want to understand whether the blood clot prevention medications that stroke patients typically take โ which help prevent future strokes โ might increase the risk of larger brain bleeding or cause more microbleeds to appear over time.
Doctors know that about 30% of stroke patients have these tiny brain bleeds, but there is not enough clear evidence about how safe blood clot prevention medication is for these patients. This study aims to fill that gap by carefully tracking whether this treatment helps or harms patients with microbleeds.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join, you will continue taking your regular stroke prevention medications while researchers track your health. You will have special brain imaging scans (MRI) done at the start and during follow-up visits over several months to see if your microbleeds change. The study involves about 1,875 patients across multiple hospitals, and your doctors will monitor you to make sure the treatment remains safe.
AI-generated summary from trial data ยท Aug 9, 2026 ยท Not medical advice
China
Sponsor
General Hospital of Shenyang Military Region
Enrollment target
~1,875 participants
Started
August 2018
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
chen huisheng, doctor
General Hospital of Shenyang Military Region
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.